These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 33387360)
1. Identification of biomarkers for drug-resistant endometriosis using clinical proteomics. Kobayashi Y; Fukutomi T; Mita S; Watanabe M; Suzuki A Hum Cell; 2021 Mar; 34(2):394-399. PubMed ID: 33387360 [TBL] [Abstract][Full Text] [Related]
2. Dienogest, a synthetic progestin, down-regulates expression of CYP19A1 and inflammatory and neuroangiogenesis factors through progesterone receptor isoforms A and B in endometriotic cells. Ichioka M; Mita S; Shimizu Y; Imada K; Kiyono T; Bono Y; Kyo S J Steroid Biochem Mol Biol; 2015 Mar; 147():103-10. PubMed ID: 25533385 [TBL] [Abstract][Full Text] [Related]
4. Dienogest: a new therapeutic agent for the treatment of endometriosis. Harada T; Taniguchi F Womens Health (Lond); 2010 Jan; 6(1):27-35. PubMed ID: 20001868 [TBL] [Abstract][Full Text] [Related]
5. Comparison of dienogest effects upon 3,3'-diindolylmethane supplementation in models of endometriosis and clinical cases. Morales-Prieto DM; Herrmann J; Osterwald H; Kochhar PS; Schleussner E; Markert UR; Oettel M Reprod Biol; 2018 Sep; 18(3):252-258. PubMed ID: 30001982 [TBL] [Abstract][Full Text] [Related]
6. Dienogest in the treatment of endometriosis. Bizzarri N; Remorgida V; Leone Roberti Maggiore U; Scala C; Tafi E; Ghirardi V; Salvatore S; Candiani M; Venturini PL; Ferrero S Expert Opin Pharmacother; 2014 Sep; 15(13):1889-902. PubMed ID: 25069386 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Dienogest for Treatment of Recurrent Endometriosis: Multicenter Data. Lee JH; Song JY; Yi KW; Lee SR; Lee DY; Shin JH; Cho S; Seo SK; Kim SH Reprod Sci; 2018 Oct; 25(10):1515-1522. PubMed ID: 29848190 [TBL] [Abstract][Full Text] [Related]
8. New treatment strategy for endometriosis using progestin-primed ovarian stimulation with dienogest: A prospective cohort study, comparison of dienogest versus dydrogesterone. Iwami N; Kawamata M; Ozawa N; Yamamoto T; Watanabe E; Mizuuchi M; Moriwaka O; Kamiya H Reprod Biol; 2021 Mar; 21(1):100470. PubMed ID: 33333410 [TBL] [Abstract][Full Text] [Related]
9. Modification of endometrioma size during hormone therapy containing dienogest. Xholli A; Filip G; Previtera F; Cagnacci A Gynecol Endocrinol; 2020 Jun; 36(6):545-549. PubMed ID: 31842632 [TBL] [Abstract][Full Text] [Related]
10. The clinical outcome of Dienogest treatment followed by in vitro fertilization and embryo transfer in infertile women with endometriosis. Tamura H; Yoshida H; Kikuchi H; Josaki M; Mihara Y; Shirafuta Y; Shinagawa M; Tamura I; Taketani T; Takasaki A; Sugino N J Ovarian Res; 2019 Dec; 12(1):123. PubMed ID: 31831028 [TBL] [Abstract][Full Text] [Related]
11. Does dienogest influence the inflammatory response of endometriotic cells? A systematic review. Grandi G; Mueller M; Bersinger NA; Cagnacci A; Volpe A; McKinnon B Inflamm Res; 2016 Mar; 65(3):183-92. PubMed ID: 26650031 [TBL] [Abstract][Full Text] [Related]
13. Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E₂ production in human endometriotic stromal cells in spheroid culture. Yamanaka K; Xu B; Suganuma I; Kusuki I; Mita S; Shimizu Y; Mizuguchi K; Kitawaki J Fertil Steril; 2012 Feb; 97(2):477-82. PubMed ID: 22130322 [TBL] [Abstract][Full Text] [Related]
14. Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study. Angioni S; Pontis A; Malune ME; Cela V; Luisi S; Litta P; Vignali M; Nappi L Gynecol Endocrinol; 2020 Jan; 36(1):84-86. PubMed ID: 31311360 [TBL] [Abstract][Full Text] [Related]
15. Dienogest regulates apoptosis, proliferation, and invasiveness of endometriotic cyst stromal cells via endoplasmic reticulum stress induction. Choi J; Jo M; Lee E; Lee DY; Choi D Mol Hum Reprod; 2020 Jan; 26(1):30-39. PubMed ID: 31814016 [TBL] [Abstract][Full Text] [Related]
16. Dienogest reduces HSD17β1 expression and activity in endometriosis. Mori T; Ito F; Matsushima H; Takaoka O; Koshiba A; Tanaka Y; Kusuki I; Kitawaki J J Endocrinol; 2015 May; 225(2):69-76. PubMed ID: 25767055 [TBL] [Abstract][Full Text] [Related]
17. Use of dienogest over 53 weeks for the treatment of endometriosis. Sugimoto K; Nagata C; Hayashi H; Yanagida S; Okamoto A J Obstet Gynaecol Res; 2015 Dec; 41(12):1921-6. PubMed ID: 26369271 [TBL] [Abstract][Full Text] [Related]
18. Dienogest improves human leucocyte antigen-DR underexpression and reduces tumour necrosis factor-α production in peritoneal fluid cells from women with endometriosis. Maeda N; Izumiya C; Taniguchi K; Matsushima S; Mita S; Shimizu Y; Fukaya T Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():48-51. PubMed ID: 24793935 [TBL] [Abstract][Full Text] [Related]
19. Risk factors for non-response and discontinuation of Dienogest in endometriosis patients: A cohort study. Nirgianakis K; Vaineau C; Agliati L; McKinnon B; Gasparri ML; Mueller MD Acta Obstet Gynecol Scand; 2021 Jan; 100(1):30-40. PubMed ID: 32767677 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Long-Term Use of Dienogest in Women With Ovarian Endometrioma. Lee SR; Yi KW; Song JY; Seo SK; Lee DY; Cho S; Kim SH Reprod Sci; 2018 Mar; 25(3):341-346. PubMed ID: 29161960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]